A retrospective analysis of US medical records of people aged 65-95 years finds those with psoriasis on systemic therapies ...

No nail changes were noted. His grandfather has a history of psoriasis. Guttate psoriasis mainly affects the trunk and proximal extremities, but may be generalized in distribution. Lesions may ...

Amgen has won FDA approval for a stronger label for its oral plaque psoriasis therapy Otezla, as it prepares for competition from Bristol-Myers Squibb's much-touted rival deucravacitinib ...

Otezla, a first-in-class treatment for plaque psoriasis has been approved in the US. Celgene's drug Otezla (apremilast) is an oral, selective inhibitor of phosphodiesterase 4 (PDE4) and gained its ...

May 27, 2025 — Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link ...

For many people with psoriasis, there are bad hair days — and then there are really bad hair days, complete with itchy, flaking scalp psoriasis that can look as icky as it feels. Scalp ...

and the divestiture of Otezla® to Amgen Appointment marks a key addition as Tonix readies for the potential approval of TNX-102 SL for the management Combination treatment of TFF2 with anti-PD1 ...